Papers by Podium Session

Session: Head and Neck Surgery 1 (Endocrine)
Date: June 3, 2019
Location: Salon 9/10

  1. 10:30 (June 3, 2019): NSD1 is a biomarker of survival in HPV-negative head and neck squamous cell carcinoma | Head and Neck Surgery 1 (Endocrine)
  2. 10:37 (June 3, 2019): Oncological and functional outcomes after repeat transoral laser microsurgery for the treatment of recurrent early glottic cancer | Head and Neck Surgery 1 (Endocrine)
  3. 10:44 (June 3, 2019): Outcomes for the Treatment of Recurrent Nasopharyngeal Cancer: A systematic review and pooled analysis | Head and Neck Surgery 1 (Endocrine)
  4. 10:58 (June 3, 2019): Outcomes of free flap reconstructions with near-infrared spectroscopy (NIRS) monitoring; a systematic review. | Head and Neck Surgery 1 (Endocrine)
  5. 11:05 (June 3, 2019): Pathologic response to neoadjuvant chemotherapy in HPV positive oropharyngeal squamous cell carcinoma | Head and Neck Surgery 1 (Endocrine)
  6. 11:12 (June 3, 2019): Specimen-oriented intraoperative margin assessment in oral cavity and oropharyngeal squamous cell carcinoma | Head and Neck Surgery 1 (Endocrine)
  7. 11:26 (June 3, 2019): Survival Outcomes for Cutaneous Melanoma of the Head and Neck: A Comparative Institutional Analysis of Survivorship using the 7th and 8th Edition AJCC Staging Guidelines | Head and Neck Surgery 1 (Endocrine)
  8. 11:33 (June 3, 2019): Survival outcomes in advanced oropharyngeal squamous cell carcinoma comparing smoking status, p16 and Ki67 expression in primary surgery versus primary chemoradiation cohorts | Head and Neck Surgery 1 (Endocrine)
  9. 11:40 (June 4, 2019): Survival Outcomes of Marijuana Users in p16 Positive Oropharynx Cancer Patients | Head and Neck Surgery 1 (Endocrine)
  10. 11:47 (June 3, 2019): The Effect of Socioeconomic Status, Length of Hospital Stay, and Post-operative Complications in Oral Cavity Squamous Cell Carcinoma | Head and Neck Surgery 1 (Endocrine)